Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Hodson

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|September 7, 2021
Diffuse large B-cell lymphoma genetics - simplifying the subtypingDaniel J Hodson
Blood|July 6, 2023
Breaking the loop in AMLDaniel J Hodson
Haematologica|September 14, 2023
Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapyMark Roschewski, Daniel J Hodson
Advances in Experimental Medicine and Biology|February 13, 2009
The role of PI3K signalling in the B cell response to antigenDaniel J Hodson, Martin Turner
Blood Cancer Discovery|June 17, 2025
The Silence of the Lambdas: Hidden Complexities in the Evolution of Double-Hit LymphomasGalina Shevchenko, Daniel J Hodson
Advances in Immunology|May 22, 2012
An emerging role of RNA-binding proteins as multifunctional regulators of lymphocyte development and functionMartin Turner, Daniel J Hodson
Blood|May 1, 2025
Class struggle in DLBCLJoanna A Krupka, Daniel J Hodson
Blood|April 11, 2019
RNA-binding proteins in hematopoiesis and hematological malignancyDaniel J Hodson, Michael Screen, Martin Turner
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2024
Genetic Manipulation and Extended Culture of Human Germinal Center B Cells to Model LymphomagenesisRachel E Fenner, Chun Gong, Daniel J Hodson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2026
Reply to: Interpreting Circulating Tumor DNA-Guided Risk Stratification After First-Line TherapyJoanna A Krupka, Alimu Dayimu, Daniel J Hodson
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|September 7, 2021
Diffuse large B-cell lymphoma genetics - simplifying the subtypingDaniel J Hodson
Blood|July 6, 2023
Breaking the loop in AMLDaniel J Hodson
Haematologica|September 14, 2023
Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapyMark Roschewski, Daniel J Hodson
Advances in Experimental Medicine and Biology|February 13, 2009
The role of PI3K signalling in the B cell response to antigenDaniel J Hodson, Martin Turner
Blood Cancer Discovery|June 17, 2025
The Silence of the Lambdas: Hidden Complexities in the Evolution of Double-Hit LymphomasGalina Shevchenko, Daniel J Hodson
Advances in Immunology|May 22, 2012
An emerging role of RNA-binding proteins as multifunctional regulators of lymphocyte development and functionMartin Turner, Daniel J Hodson
Blood|May 1, 2025
Class struggle in DLBCLJoanna A Krupka, Daniel J Hodson
Blood|April 11, 2019
RNA-binding proteins in hematopoiesis and hematological malignancyDaniel J Hodson, Michael Screen, Martin Turner
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2024
Genetic Manipulation and Extended Culture of Human Germinal Center B Cells to Model LymphomagenesisRachel E Fenner, Chun Gong, Daniel J Hodson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2026
Reply to: Interpreting Circulating Tumor DNA-Guided Risk Stratification After First-Line TherapyJoanna A Krupka, Alimu Dayimu, Daniel J Hodson
Pageof 6